Venus Remedies up 4% after entering license agreement with UK-based Infex
The agreement authorises Venus Remedies to spearhead the clinical development, registration, and commercialisation of MET-X, ...
money.rediff8m
Venus Remedies Partners with UK Firm to Develop MET-X for Drug-Resistant Infections
Venus Remedies has partnered with Infex Therapeutics to develop MET-X, an innovative metallo-beta-lactamase inhibitor, to ...
cnbctv1827m
Venus Remedies gains 4% on securing rights to commercialise MBL inhibitor in India
The deal grants Venus Remedies the rights to develop, register, and commercialise MET-X, a novel metallo-beta-lactamase (MBL) ...
gematsu39m
Venus Vacation PRISM: DEAD OR ALIVE Xtreme ‘Illustrator Yom Exclusive Episodes’ trailer, details, and screenshots
Publisher Koei Tecmo and developer Team NINJA have released a new trailer, information, and screenshots for Venus Vacation PRISM: DEAD OR ALIVE Xtreme, introducing the collaboration episodes with ...
Venus Remedies gains on strategic MET-X partnership
Venus Remedies rose 2.15% to Rs 313.65 after the company said it secured exclusive in-licensing rights from UK's Infex Therapeutics to develop and commercialize MET-X in India.
Horoscope today: Your daily guide for Tuesday, February 25, 2025
Your daily guide for Tuesday, February 25, 2025 - Read what the stars mean for you today, from Pisces to Gemini ...